Comparative erythropoietin receptor binding kinetics of C.E.R.A. and epoetin-β determined by surface plasmon resonance and competition binding assay

Pharmacology

Volumn 81, Issue 1, 2007, Pages 63-69

  Jarsch, Michael ^a   Brandt, Michael ^a   Lanzendörfer, Martin ^a   Haselbeck, Anton ^a  

^a ROCHE DIAGNOSTICS GMBH   (Germany)

Author keywords

Anemia management; Erythropoiesis; Hemoglobin; Receptor binding kinetics; Surface plasmon resonance

Indexed keywords

CONTINUOUS ERYTHROPOIESIS RECEPTOR ACTIVATOR; ERYTHROPOIETIN RECEPTOR; RECOMBINANT ERYTHROPOIETIN;

ARTICLE; BINDING ASSAY; BINDING SITE; CALCULATION; CELL CULTURE; COMPARATIVE STUDY; CONTROLLED STUDY; DISSOCIATION CONSTANT; DRUG DETERMINATION; DRUG RECEPTOR BINDING; ERYTHROPOIESIS; HUMAN; HUMAN CELL; IC 50; PRIORITY JOURNAL; RECEPTOR AFFINITY; STIMULATION; SURFACE PLASMON RESONANCE;

BINDING, COMPETITIVE; BIOSENSING TECHNIQUES; CELL CULTURE TECHNIQUES; CELL LINE, TUMOR; ERYTHROPOIETIN; ERYTHROPOIETIN, RECOMBINANT; HUMANS; POLYETHYLENE GLYCOLS; RADIOLIGAND ASSAY; RECEPTORS, ERYTHROPOIETIN; SURFACE PLASMON RESONANCE;

EID: 35448933079     PISSN: 00317012     EISSN: None     Source Type: Journal    
DOI: 10.1159/000109166     Document Type: Article

References (29)

1. Jacobs K, Shoemaker C, Rudersdorf R, Neill SD, Kaufman RJ, Mufson A, Seehra J, Jones SS, Hewick R, Fritsch EF, Kawakita M, Shimizu T, Miyake T: Isolation and characterization of genomic and cDNA clones of human erythropoietin. Nature 1985;313:806-810.
2. Lin FK, Suggs S, Lin CH, Browne JK, Smalling R, Egrie JC, Chen KK, Fox GM, Martin F, Stabinsky Z, Badrawi SM, Lai P-H, Goldwasser E: Cloning and expression of the human erythropoietin gene. Proc Natl Acad Sci USA 1985;82:7580-7584.
3. Sawyer ST, Krantz SB, Goldwasser E: Binding and receptor-mediated endocytosis of erythropoietin in Friend virus-infected erythroid cells. J Biol Chem 1987;262:5554-5562.
4. Macdougall IC: CERA (continuous erythropoietin receptor activator): a new erythropoiesis-stimulating agent for the treatment of anemia. Curr Hematol Rep 2005;4:436-440.
5. Macdougall IC, Eckardt KU: Novel strategies for stimulating erythropoiesis and potential new treatments for anaemia. Lancet 2006;368:947-953.
6. Jarsch M, Kubbies M, Lanzendörfer M, Haselbeck A, Brandt M: CERA acts differently at the erythropoietin (EPO) receptor compared with epoetin beta: UT-7 and CD34+ cell stimulation assays. J Am Soc Nephrol 2006;17:619A (abstract SA-PO209).
7. Biacore Sensor Surface Handbook, Edition October (Version AA). Uppsala, Biacore, 2003.
8. Cooper MA: Optical biosensors in drug discovery. Nat Rev Drug Discov 2002;1:515-528.
9. Karlsson R, Falt A: Experimental design for the kinetic analysis of protein-protein interactions with surface plasmon resonance biosensors. J Immunol Methods 1997;200:121-133.
10. Morton TA, Myszka DG: Kinetic analysis of macromolecular interactions using surface plasmon resonance biosensors. Methods Enzymol 1998;295:268-294.
11. Malmquist M: BIACORE: an affinity biosensor system for characterization of biomolecular interactions. Biochem Soc Trans 1999;27:335-340.
12. Myszka DG, Rich RL: Implementing surface plasmon resonance biosensors in drug discovery. Pharm Sci Technol Today 2000;3:310-317.
13. Nagata K, Handa H: Real-Time Analysis of Biomolecular Interactions. Applications of Biacore. Tokyo, Springer-Verlag, 2000.
14. Rich RL, Myszka DG: Advances in surface plasmon resonance biosensor analysis. Curr Opin Biotechnol 2000;11:54-61.
15. Komatsu N, Nakauchi H, Miwa A, Ishihara T, Eguchi M, Moroi M, Okada M, Sato Y, Wada H, Yawata Y, Suda T, Miura Y: Establishment and characterization of a human leukemic cell line with megakaryocytic features: dependency on granulocyte-macrophage colony-stimulating factor, interleukin 3, or erythropoietin for growth and survival. Cancer Res 1991;51:341-348.
16. Drexler HG, Zaborski M, Quentmeier H: Cytokine response profiles of human myeloid factor-dependent leukemia cell lines. Leukemia 1997;11:701-708.
17. Mufson RA, Gesner TG: Binding and internalisation of recombinant human erythropoietin in murine erythroid precursor cells. Blood 1987;69:1485-1490.
18. Krantz SB, Goldwasser E: Specific binding of erythropoietin to spleen cells infected with the anemia strain of Friend virus. Proc Natl Acad Sci USA 1984;81:7574-7578.
19. Mayeux P, Billat C, Jacquot R: The erythropoietin receptor of rat erythroid progenitor cells. J Biol Chem 1987;262:13985-13990.
20. Fishbane S: Recombinant human erythropoietin: has treatment reached its full potential? Semin Dial 2006;19:1-4.
21. Philo JS, Aoki KH, Arakawa T, Narhi LO, Wen J: Dimerization of the extracellular domain of the erythropoietin (EPO) receptor by EPO: one high-affinity and one low-affinity interaction. Biochemistry 1996;35:1681-1691.
22. Damen JE, Krystal G: Early events in erythropoietin-induced signalling. Exp Hematol 1996;24:1455-1459.
23. Syed R, Reid SW, Li C, Cheetham JC, Aoki KH, Liu B, Zhan H, Osslund TD, Chirino AJ, Zhang J, Finer-Moore J, Elliott S, Sitney K, Katz BA, Matthews DJ, Wendoloski JJ, Egrie J, Stroud RM: Efficiency of signalling through cytokine receptors depends critically on receptor orientation. Nature 1998;395:511-516.
24. Constantinescu SN, Ghaffari S, Lodish HF: The erythropoietin receptor: structure, activation and intracellular signal transduction. Trends Endocrinol Metab 1999;10:18-23.
25. Gross AW, Lodish HF: Cellular trafficking and degradation of erythropoietin and novel erythropoiesis stimulating protein (NESP). J Biol Chem 2006;281:2024-2032.
26. Macdougall IC, Robson R, Opatrna S, Liogier X, Pannier A, Jordan P, Dougherty FC, Reigner B: Pharmacokinetics and pharmacodynamics of intravenous and subcutaneous continuous erythropoietin receptor activator (C.E.R.A.) in patients with chronic kidney disease. Clin J Am Soc Nephrol 2006;1:1211-1215.
27. Halstenson CE, Macres M, Katz SA, Schnieders JR, Watanabe M, Sobota JT, Abraham PA: Comparative pharmacokinetics and pharmacodynamics of epoetin alfa and epoetin beta. Clin Pharmacol Ther 1991;50:702-712.
28. Sarkar CA, Lowenhaupt K, Wang PJ, Horan T, Lauffenburger DA: Parsing the effects of binding, signaling, and trafficking on the mitogenic potencies of granulocyte colonystimulating factor analogues. Biotechnol Prog 2003;19:955-964.
29. Macdougall IC, Gray SJ, Elston O, Breen C, Jenkins B, Browne J, Egrie J: Pharmacokinetics of novel erythropoiesis stimulating protein compared with epoetin alfa in dialysis patients. J Am Soc Nephrol 1999;10:2392-2395.